Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro

David Hasdai, Robert A. Rizza, David Holmes, Darcy M. Richardson, Pinchas Cohen, Amir Lerman

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Insulin and insulin-like growth factor-I (IGF-I) may play a role in the modulation of coronary artery tone, yet there are few data regarding their vasoactive effects on the coronary vascular bed. We evaluated the vasorelaxation effects of insulin and IGF-I on porcine coronary epicardial vessels in vitro and elucidated possible mechanisms. Porcine epicardial arteries were contracted with 10 -7 mol/L endothelin-1 and relaxed with cumulative concentrations of either insulin or IGF-I (10 -12 to 10 -7 mol/L). The above experiments were repeated in vessels without endothelium. Vessels were also incubated with the nitric oxide synthase inhibitor N(G)- monomethyl-L-arginine (L-NMMA; 10 -4 mol/L) with and without 10 -3.5 mol/L L-arginine, the potassium channel blocker tetraethylammonium (TEA; 10 -2 mol/L), and the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,- α]quinoxalin-1-one (ODQ; 10 -5.5 mol/L); vessels were then contracted with endothelin-1 and relaxed with insulin or IGF-I. Insulin and IGF-I were also added after contraction with 60 mmol/L KCl. Insulin and IGF-I caused a similar decrease in coronary epicardial tension after contraction with endothelin-1 (relaxation of 28±4% [n=7] and 25±3% [n=8] with insulin and IGF-I, respectively; P<0.0001 for both peptides). Removal of the endothelium did not affect these responses. Incubation with L-NMMA, but not ODQ, attenuated the vasorelaxation response to insulin and IGF in vessels without endothelium. L-Arginine did not reverse this effect of L-NMMA. KCl nd TEA attenuated the vasorelaxation effect of both insulin and IGF-I. Thus, both insulin and IGF-I caused non-endothelium-dependent coronary vasorelaxation in vitro, probably through a mechanism involving the activation of potassium channels. These findings suggest that insulin and IGF-I participate in the regulation of coronary vasomotor tone.

Original languageEnglish (US)
Pages (from-to)228-234
Number of pages7
JournalHypertension
Volume32
Issue number2
StatePublished - Aug 1998

Fingerprint

Insulin-Like Growth Factor I
Vasodilation
Insulin
omega-N-Methylarginine
Endothelin-1
Endothelium
Arginine
Coronary Vessels
In Vitro Techniques
Swine
Potassium Channel Blockers
Quinoxalines
Tetraethylammonium
Guanylate Cyclase
Potassium Channels
Nitric Oxide Synthase
Blood Vessels
Arteries
Peptides

Keywords

  • Arteries
  • Endothelium
  • Growth factors
  • Insulin
  • Nitric oxide
  • Pigs
  • Potassium channels

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Hasdai, D., Rizza, R. A., Holmes, D., Richardson, D. M., Cohen, P., & Lerman, A. (1998). Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. Hypertension, 32(2), 228-234.

Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. / Hasdai, David; Rizza, Robert A.; Holmes, David; Richardson, Darcy M.; Cohen, Pinchas; Lerman, Amir.

In: Hypertension, Vol. 32, No. 2, 08.1998, p. 228-234.

Research output: Contribution to journalArticle

Hasdai, D, Rizza, RA, Holmes, D, Richardson, DM, Cohen, P & Lerman, A 1998, 'Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro', Hypertension, vol. 32, no. 2, pp. 228-234.
Hasdai, David ; Rizza, Robert A. ; Holmes, David ; Richardson, Darcy M. ; Cohen, Pinchas ; Lerman, Amir. / Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. In: Hypertension. 1998 ; Vol. 32, No. 2. pp. 228-234.
@article{bcbe5de53ef5411a84a230d1adf9a645,
title = "Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro",
abstract = "Insulin and insulin-like growth factor-I (IGF-I) may play a role in the modulation of coronary artery tone, yet there are few data regarding their vasoactive effects on the coronary vascular bed. We evaluated the vasorelaxation effects of insulin and IGF-I on porcine coronary epicardial vessels in vitro and elucidated possible mechanisms. Porcine epicardial arteries were contracted with 10 -7 mol/L endothelin-1 and relaxed with cumulative concentrations of either insulin or IGF-I (10 -12 to 10 -7 mol/L). The above experiments were repeated in vessels without endothelium. Vessels were also incubated with the nitric oxide synthase inhibitor N(G)- monomethyl-L-arginine (L-NMMA; 10 -4 mol/L) with and without 10 -3.5 mol/L L-arginine, the potassium channel blocker tetraethylammonium (TEA; 10 -2 mol/L), and the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,- α]quinoxalin-1-one (ODQ; 10 -5.5 mol/L); vessels were then contracted with endothelin-1 and relaxed with insulin or IGF-I. Insulin and IGF-I were also added after contraction with 60 mmol/L KCl. Insulin and IGF-I caused a similar decrease in coronary epicardial tension after contraction with endothelin-1 (relaxation of 28±4{\%} [n=7] and 25±3{\%} [n=8] with insulin and IGF-I, respectively; P<0.0001 for both peptides). Removal of the endothelium did not affect these responses. Incubation with L-NMMA, but not ODQ, attenuated the vasorelaxation response to insulin and IGF in vessels without endothelium. L-Arginine did not reverse this effect of L-NMMA. KCl nd TEA attenuated the vasorelaxation effect of both insulin and IGF-I. Thus, both insulin and IGF-I caused non-endothelium-dependent coronary vasorelaxation in vitro, probably through a mechanism involving the activation of potassium channels. These findings suggest that insulin and IGF-I participate in the regulation of coronary vasomotor tone.",
keywords = "Arteries, Endothelium, Growth factors, Insulin, Nitric oxide, Pigs, Potassium channels",
author = "David Hasdai and Rizza, {Robert A.} and David Holmes and Richardson, {Darcy M.} and Pinchas Cohen and Amir Lerman",
year = "1998",
month = "8",
language = "English (US)",
volume = "32",
pages = "228--234",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro

AU - Hasdai, David

AU - Rizza, Robert A.

AU - Holmes, David

AU - Richardson, Darcy M.

AU - Cohen, Pinchas

AU - Lerman, Amir

PY - 1998/8

Y1 - 1998/8

N2 - Insulin and insulin-like growth factor-I (IGF-I) may play a role in the modulation of coronary artery tone, yet there are few data regarding their vasoactive effects on the coronary vascular bed. We evaluated the vasorelaxation effects of insulin and IGF-I on porcine coronary epicardial vessels in vitro and elucidated possible mechanisms. Porcine epicardial arteries were contracted with 10 -7 mol/L endothelin-1 and relaxed with cumulative concentrations of either insulin or IGF-I (10 -12 to 10 -7 mol/L). The above experiments were repeated in vessels without endothelium. Vessels were also incubated with the nitric oxide synthase inhibitor N(G)- monomethyl-L-arginine (L-NMMA; 10 -4 mol/L) with and without 10 -3.5 mol/L L-arginine, the potassium channel blocker tetraethylammonium (TEA; 10 -2 mol/L), and the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,- α]quinoxalin-1-one (ODQ; 10 -5.5 mol/L); vessels were then contracted with endothelin-1 and relaxed with insulin or IGF-I. Insulin and IGF-I were also added after contraction with 60 mmol/L KCl. Insulin and IGF-I caused a similar decrease in coronary epicardial tension after contraction with endothelin-1 (relaxation of 28±4% [n=7] and 25±3% [n=8] with insulin and IGF-I, respectively; P<0.0001 for both peptides). Removal of the endothelium did not affect these responses. Incubation with L-NMMA, but not ODQ, attenuated the vasorelaxation response to insulin and IGF in vessels without endothelium. L-Arginine did not reverse this effect of L-NMMA. KCl nd TEA attenuated the vasorelaxation effect of both insulin and IGF-I. Thus, both insulin and IGF-I caused non-endothelium-dependent coronary vasorelaxation in vitro, probably through a mechanism involving the activation of potassium channels. These findings suggest that insulin and IGF-I participate in the regulation of coronary vasomotor tone.

AB - Insulin and insulin-like growth factor-I (IGF-I) may play a role in the modulation of coronary artery tone, yet there are few data regarding their vasoactive effects on the coronary vascular bed. We evaluated the vasorelaxation effects of insulin and IGF-I on porcine coronary epicardial vessels in vitro and elucidated possible mechanisms. Porcine epicardial arteries were contracted with 10 -7 mol/L endothelin-1 and relaxed with cumulative concentrations of either insulin or IGF-I (10 -12 to 10 -7 mol/L). The above experiments were repeated in vessels without endothelium. Vessels were also incubated with the nitric oxide synthase inhibitor N(G)- monomethyl-L-arginine (L-NMMA; 10 -4 mol/L) with and without 10 -3.5 mol/L L-arginine, the potassium channel blocker tetraethylammonium (TEA; 10 -2 mol/L), and the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,- α]quinoxalin-1-one (ODQ; 10 -5.5 mol/L); vessels were then contracted with endothelin-1 and relaxed with insulin or IGF-I. Insulin and IGF-I were also added after contraction with 60 mmol/L KCl. Insulin and IGF-I caused a similar decrease in coronary epicardial tension after contraction with endothelin-1 (relaxation of 28±4% [n=7] and 25±3% [n=8] with insulin and IGF-I, respectively; P<0.0001 for both peptides). Removal of the endothelium did not affect these responses. Incubation with L-NMMA, but not ODQ, attenuated the vasorelaxation response to insulin and IGF in vessels without endothelium. L-Arginine did not reverse this effect of L-NMMA. KCl nd TEA attenuated the vasorelaxation effect of both insulin and IGF-I. Thus, both insulin and IGF-I caused non-endothelium-dependent coronary vasorelaxation in vitro, probably through a mechanism involving the activation of potassium channels. These findings suggest that insulin and IGF-I participate in the regulation of coronary vasomotor tone.

KW - Arteries

KW - Endothelium

KW - Growth factors

KW - Insulin

KW - Nitric oxide

KW - Pigs

KW - Potassium channels

UR - http://www.scopus.com/inward/record.url?scp=0031867143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031867143&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 228

EP - 234

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -